Search

everythinglearnresearchcommunity

for

Search:↓

Most 46XX CAH patients have female identity, but a few identify as male and may need treatment and surgery.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Isolated pubic hair in infants is usually harmless and resolves on its own.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Microemulsions could improve how drugs are delivered and absorbed in the body.

Technology can improve sexual dysfunction in chronic disease patients but faces challenges like cost and accessibility.

Many women in Northern Ghana use plant-based cosmetics like shea butter, and their use is more related to being married than to their job, education, or house.

A 19-year-old with MRKHS developed complete hair loss, and treatment options were discussed.

New treatments and technologies in laser medicine show promise for improving skin conditions, fat reduction, cancer treatment, wound healing, and hair restoration.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Many survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Togo suffer long-term eye and skin problems.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.